Company intelligence / Profile preview

Infomed

Meinier, Geneva, Switzerland

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Infomed's devices for blood purification and renal replacement (including DIMI and SAMI) are marketed in Europe and Asia, and are actively being commercialized in North America via the i-Dialco joint venture. The company is a recognized innovator with patents and a global installed base[1][4][6][7].

Therapeutic areas: NephrologyImmunologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Spectral Medical (joint venture for North American commercialization via i-Dialco)[6]Baxter (indirect distribution via Spectral partnership)[6]

Beyond the preview

Go deeper on Infomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infomed.

Explore the full profile